Published in Stroke on May 20, 2004
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol (2009) 6.02
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol (2008) 2.40
Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol (2010) 1.96
Microbleeds versus macrobleeds: evidence for distinct entities. Stroke (2009) 1.83
Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron (2013) 1.54
Chronic cigarette smoking: implications for neurocognition and brain neurobiology. Int J Environ Res Public Health (2010) 1.36
Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke (2014) 1.32
Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology (2010) 1.29
Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Front Neurol (2014) 1.27
Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging (2010) 1.25
APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis. Neurology (2013) 1.14
Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms. Nutr Neurosci (2013) 1.03
Genetic associations with brain microbleeds: Systematic review and meta-analyses. Neurology (2011) 0.97
Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds. Neuropathol Appl Neurobiol (2014) 0.93
Racial differences in microbleed prevalence in primary intracerebral hemorrhage. Neurology (2008) 0.93
Cerebral microbleeds: their associated factors, radiologic findings, and clinical implications. J Stroke (2013) 0.93
Lipoprotein phospholipase A2 and cerebral microbleeds in the Framingham Heart Study. Stroke (2012) 0.93
Structural imaging measures of brain aging. Neuropsychol Rev (2014) 0.91
Focal hemosiderin deposits and β-amyloid load in the ADNI cohort. Alzheimers Dement (2013) 0.91
Intracerebral hemorrhage and deep microbleeds associated with cnm-positive Streptococcus mutans; a hospital cohort study. Sci Rep (2016) 0.86
Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the Future. Am J Hypertens (2015) 0.86
Risk Factors Associated With Incident Cerebral Microbleeds According to Location in Older People: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study. JAMA Neurol (2015) 0.84
Incidental Cerebral Microbleeds and Cerebral Blood Flow in Elderly Individuals. JAMA Neurol (2015) 0.83
The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice. Neurobiol Aging (2015) 0.83
Cerebral microbleeds in a multiethnic elderly community: demographic and clinical correlates. J Neurol Sci (2014) 0.82
Profiles by sex of brain MRI and cognitive function in the framingham offspring study. Alzheimer Dis Assoc Disord (2010) 0.82
Differential risk factors for lacunar stroke depending on the MRI (white and red) subtypes of microangiopathy. PLoS One (2012) 0.81
Cerebral microbleeds: a new dilemma in stroke medicine. JRSM Cardiovasc Dis (2012) 0.81
Hockey Concussion Education Project, Part 1. Susceptibility-weighted imaging study in male and female ice hockey players over a single season. J Neurosurg (2014) 0.81
Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice. Trends Neurosci (2016) 0.81
Clinical Outcome in Acute Ischemic Stroke Patients With Microbleeds After Thrombolytic Therapy: A Meta-Analysis. Medicine (Baltimore) (2015) 0.81
Severe underweight and cerebral microbleeds. J Neurol (2012) 0.80
Stroke prevention and cognitive reserve: emerging approaches to modifying risk and delaying onset of dementia. Front Neurol (2013) 0.80
Clopidogrel use is associated with an increased prevalence of cerebral microbleeds in a stroke-free population: the Rotterdam study. J Am Heart Assoc (2013) 0.80
Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis. J Neurol Neurosurg Psychiatry (2015) 0.79
is leukoaraiosis on CT an accurate surrogate marker for the presence of microbleeds in acute stroke patients? J Neurol (2007) 0.79
Cerebral microhemorrhages in a collegiate football player: clinical implications in the management of sports concussion. Sports Health (2010) 0.78
Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke (2017) 0.78
Cerebral microbleeds and cognitive decline in a hemodialysis patient: Case report and review of literature. Hemodial Int (2014) 0.77
Incidental Intracranial Findings and Their Clinical Impact; The HUNT MRI Study in a General Population of 1006 Participants between 50-66 Years. PLoS One (2016) 0.76
APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds. Int J Stroke (2015) 0.76
Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors. Alzheimers Dement (Amst) (2016) 0.75
Baseline characteristics in stroke patients with atrial fibrillation: clinical trials versus clinical practice. BMC Res Notes (2015) 0.75
Cerebral amyloid angiopathy. BMJ Case Rep (2014) 0.75
Cerebral microbleeds are associated with deep white matter hyperintensities, but only in hypertensive patients. PLoS One (2014) 0.75
Brain microbleeds: distribution and influence on hematoma and perihematomal edema in patients with primary intracerebral hemorrhage. Neuroradiol J (2013) 0.75
Cerebral Microbleeds, Vascular Risk Factors, and Magnetic Resonance Imaging Markers: The Northern Manhattan Study. J Am Heart Assoc (2016) 0.75
Kidney dysfunction and cerebral microbleeds in neurologically healthy adults. PLoS One (2017) 0.75
Cerebral microbleeds in patients with Parkinson's disease. J Neurol (2014) 0.75
Cerebral microhemorrhages: mechanisms, consequences and prevention. Am J Physiol Heart Circ Physiol (2017) 0.75
Prevalence of Cerebral Microbleeds in Thai Patients with Ischemic Stroke. J Neurosci Rural Pract (2017) 0.75
Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease. Neurobiol Aging (2017) 0.75
Influence of preeclampsia and late-life hypertension on MRI measures of cortical atrophy. J Hypertens (2017) 0.75
General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med (2002) 11.20
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80
Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27
Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med (2004) 7.12
Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med (2010) 7.03
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA (2002) 6.84
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation (2003) 6.83
Obesity and the risk of new-onset atrial fibrillation. JAMA (2004) 6.73
Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med (2004) 6.42
Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation (2006) 5.97
Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation (2008) 5.95
Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med (2011) 5.94
Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging (2005) 5.84
Percutaneous repair or surgery for mitral regurgitation. N Engl J Med (2011) 5.78
Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med (2007) 5.77
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord (2009) 5.50
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation (2007) 5.10
The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet (2007) 5.02
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA (2004) 4.85
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA (2003) 4.77
Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med (2008) 4.72
The lifetime risk of stroke: estimates from the Framingham Study. Stroke (2006) 4.68
Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation (2009) 4.62
Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke (2004) 4.56
Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics. Stat Med (2003) 4.07
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92
Depressive symptoms and risk of stroke: the Framingham Study. Stroke (2006) 3.80
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol (2003) 3.75
Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke (2010) 3.75
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Vascular cognitive impairment. Lancet Neurol (2003) 3.73
Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA (2009) 3.62
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology (2010) 3.60
Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J (2009) 3.54
Dementia after stroke: the Framingham Study. Stroke (2004) 3.53
Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA (2006) 3.50
Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab (2010) 3.39
Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2014) 3.36
Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke (2009) 3.23
The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovasc Dis (2007) 3.22
Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke (2004) 3.13
Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med (2010) 3.05
Visceral fat is associated with lower brain volume in healthy middle-aged adults. Ann Neurol (2010) 3.05